A Phase 3, Randomized, Multicenter Study Comparing the Safety and Efficacy of Oral Febuxostat Versus Allopurinol in Subjects With Gout
收藏DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00002435/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
提供机构：
Vivli
创建时间：
2018-10-27
